Page last updated: 2024-08-23

diltiazem and ta 993

diltiazem has been researched along with ta 993 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (60.00)18.2507
2000's4 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doi, H; Kaburaki, M; Murata, S; Narita, H; Yasoshima, A1
Katoh, M; Kikkawa, K; Odawara, A; Sasaki, Y; Shimazaki, T; Toryu, H1
Doi, H; Kaburaki, M; Karasawa, T; Murata, S; Narita, H; Yabana, H1
Doi, H; Inoue, H; Kaburaki, M; Narita, H; Yasuhara, M1
Doi, H; Kaburaki, M; Murata, S; Narita, H; Odawara, A; Yasoshima, A1
Doi, H; Kaburaki, M; Murata, S; Nagata, K; Narita, H; Yabana, H1
Doi, H; Ikeo, T; Karasawa, T; Katoh, M; Narita, H; Odawara, A; Takagi, M1
Doi, H; Inoue, H; Kaburaki, M; Narita, H; Suzumura, K1
Ikeo, T; Karasawa, T; Katoh, M; Odawara, A; Takagi, M; Watanabe, A1
Doi, H; Karasawa, T; Katoh, M; Odawara, A1

Other Studies

10 other study(ies) available for diltiazem and ta 993

ArticleYear
Antithrombotic effect of TA-993, a novel 1,5-benzothiazepine derivative, in conscious rats.
    Japanese journal of pharmacology, 1995, Volume: 68, Issue:4

    Topics: Administration, Oral; Animals; Antithrombins; Aspirin; Diltiazem; Dose-Response Relationship, Drug; Embolism; Male; Microscopy, Electron; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombosis; Ticlopidine; Time Factors

1995
Inhibitory effects of TA-993, a new 1,5-benzothiazepine derivative, on platelet aggregation.
    Circulation research, 1996, Volume: 78, Issue:4

    Topics: Animals; Aspirin; Basilar Artery; Calcium; Diltiazem; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Fibrinolytic Agents; Humans; Male; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Ticlopidine; Vasoconstriction

1996
Cardiovascular effect of a new 1,5-benzothiazepine derivative TA-993 in anesthetized dogs.
    Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:2

    Topics: Animals; Brachial Artery; Cardiovascular Agents; Carotid Arteries; Diltiazem; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Female; Femoral Artery; Ganglionic Blockers; Hemodynamics; Hexamethonium; Injections, Intravenous; Male; Regional Blood Flow; Time Factors; Vasodilation

1998
Cardiovascular effects of 1,5-benzothiazepine derivatives having a l-cis and d-cis configuration in anesthetized dogs.
    Biological & pharmaceutical bulletin, 1998, Volume: 21, Issue:1

    Topics: Anesthesia; Animals; Arteries; Calcium Channel Blockers; Diltiazem; Dogs; Female; Hemodynamics; In Vitro Techniques; Male; Molecular Conformation; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Regional Blood Flow

1998
Antithrombotic action of TA-993, a new 1,5-benzothiazepine derivative, in a canine model of femoral arterial thrombosis.
    Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:3

    Topics: Animals; Antithrombins; Diltiazem; Disease Models, Animal; Dogs; Duodenum; Electric Stimulation; Female; Femoral Artery; Male; Microscopy, Electron, Scanning; Platelet Aggregation Inhibitors; Regional Blood Flow; Thrombosis

1998
The mechanism of the increasing action of TA-993, a new 1,5- benzothiazepine derivative, on limb blood flow in anesthetized dogs: selective suppression of sympathetic nerve activity.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:3

    Topics: Animals; Diltiazem; Hindlimb; Perfusion; Platelet Aggregation Inhibitors; Regional Blood Flow; Sympathetic Nervous System

1999
Antiplatelet mechanisms of TA-993 and its metabolite MB3 in ADP-induced platelet aggregation.
    European journal of pharmacology, 2000, Jul-07, Volume: 399, Issue:2-3

    Topics: Actins; Adenosine Diphosphate; Blood Platelets; Calcium; Cyclic AMP; Cyclic GMP; Diltiazem; Dose-Response Relationship, Drug; Fibrinogen; Fura-2; Humans; Male; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding

2000
Protective effect of TA-993, a novel therapeutic agent for peripheral circulatory insufficiency, on skeletal muscle fatigue in a rat model of hindlimb ischemia.
    Japanese journal of pharmacology, 2000, Volume: 83, Issue:1

    Topics: Animals; Blood Pressure; Blood Viscosity; Diltiazem; Heart Rate; Hindlimb; Ischemia; Muscle Fatigue; Pentoxifylline; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Regional Blood Flow

2000
Inhibitory effects of TA-993 and its metabolite MB3 on platelet activation induced by collagen and U-46619 in human platelets.
    Biological & pharmaceutical bulletin, 2001, Volume: 24, Issue:5

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Calcium; Collagen; Diltiazem; Humans; Male; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2

2001
Effects of the antiplatelet agent TA-993 and its metabolite MB3 on the hemorheological properties of rat and human erythrocytes.
    Thrombosis research, 2001, Oct-15, Volume: 104, Issue:2

    Topics: Animals; Aspirin; Blood Viscosity; Diltiazem; Dose-Response Relationship, Drug; Erythrocytes; Hemolysis; Hemorheology; Humans; Phospholipids; Platelet Aggregation Inhibitors; Rats; Ticlopidine

2001